Results 101 to 110 of about 79,696 (205)

2. Phosphodiesterase-5 Inhibitors.

Nihon Naika Gakkai Zasshi, 2010
Hiroshi Kimura, Kaoru Hamada
openaire   +2 more sources

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry. [PDF]

Respir Res, 2023
Garcia AR, Blanco I, Ramon L, Pérez-Sagredo J, Guerra-Ramos FJ, Martín-Ontiyuelo C, Tura-Ceide O, Pastor-Pérez F, Escribano-Subías P, Barberà JA.   +9 more
europepmc   +1 more source

Phosphodiesterase-5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure. [PDF]

ESC Heart Fail, 2023
Papathanasiou M, Jakstaite AM, Mincu R, Wernhart S, Ruhparwar A, Rassaf T, Luedike P.   +6 more
europepmc   +1 more source

Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity. [PDF]

Bioorg Med Chem Lett, 2023
Zuccarello E, Zhang H, Acquarone E, Pham D, Staniszewski A, Deng SX, Landry DW, Arancio O, Fiorito J.   +8 more
europepmc   +1 more source

Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19? [PDF]

Mol Cell Biochem, 2023
Kukreja RC, Wang R, Koka S, Das A, Samidurai A, Xi L.   +5 more
europepmc   +1 more source

Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction. [PDF]

Sex Med, 2023
Kilic M, Caglayan V, Sambel M, Erdogan A, Onen E, Kurtoglu U, Erkan A, Avci S, Ekici O.   +8 more
europepmc   +1 more source

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2015
Abassi, Zaid, Armaly, Zaher
openaire   +2 more sources

Avanafil for treatment of erectile dysfunction: review of its potential

Vascular Health and Risk Management, 2012
Ryan M Burke,1 Jeffery D Evans21The University of Louisiana at Monroe College of Pharmacy, Monroe, LA, 2The University of Louisiana at Monroe College of Pharmacy, Shreveport, LA, USAAbstract: Avanafil is a medication that was recently approved by the US ...
Burke RM, Evans JD
doaj  

Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety. [PDF]

Cardiovasc Drugs Ther, 2023
Roy S, Kloner RA, Salloum FN, Jovin IS.
europepmc   +1 more source

Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction

Терапевтический архив, 2009
Aim. To study the influence of long-term of vardenafil use on endothelial and erectile functions in patients with arteriogenic erectile dysfunction (ED) Subjects and methods. The study included 74 arteriogenic ED patients (mean age 57.4 ± 4.7 years).
Safar Israilovich Gamidov, Dmitriy Viktorovich Shcherbakov, Regina Amirbekovna Tkhagapsoeva, Roman Vladimirovich Koroteev, S I Gamidov, D V Shcherbakov, R A Tkhagapsoyeva, R V Koroteyev   +7 more
doaj